Source: International Congress 2017 – COPD management: new findings from large studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Han (Ann Arbor, United States of America). Association between emphysema, exacerbations and mortality in the COPDGene and SPIROMICS cohorts. 1496

Member's Comments

No comment yet.

Related content which might interest you: Corerelation of COPD exacerbation with comorbidities, Lung function and mortality within a single-practice primary-care cohort in the UK Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Lung core-predominant emphysema is associated with higher symptom burden in COPD: analysis of the COPDGene cohort Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 The ICE study, Italian costs for exacerbations in COPD: a project of the Italian Association for COPD Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD Year: 2003 Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit Source: Eur Respir J 2016; 47: 113-121 Year: 2016 Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Predictors of long-term mortality after hospitalization for COPD; A Scandinavian multicentre study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 COPD exacerbation admissions: Analysis of demographics and mortality Source: Annual Congress 2013 –COPD treatment Year: 2013 Interferon-lambda-genotype GG and IgG2 are predictors for frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS) Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016 COPD exacerbations in hypertensive patients in two ethnic groups in Macedonia Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 One-year mortality in COPD patients after severe exacerbation Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Hospital adherence to GOLD guidelines for COPD exacerbation. Results of the European CODP audit Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Role of comorbidities on mortality in patients hospitalized for COPD exacerbations Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Survival in COPD patients with hospitalization due to exacerbation Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS) Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016 Statin use and risk of exacerbations in individuals with COPD: The Copenhagen general population study Source: International Congress 2014 – New insights into the epidemiology of COPD Year: 2014 The prevalence of co-morbidities and exacerbations in COPD patients in Slovenia Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Cardiovascular risk assessment in COPD patients with severe exacerbation Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Agreement of severity stages and exacerbations building the new COPD risk groups Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013